%0 Journal Article
%T Antibodies to Helminth Defense Molecule-1 are associated with inflammation, organomegaly, and decreased nutritional status in schistosomiasis japonica.
%A Ruiz AE
%A Pond-Tor S
%A Stuart R
%A Acosta LP
%A Coutinho HM
%A Leenstra T
%A Fisher S
%A Fahey O
%A McDonald EA
%A Jiz MA
%A Olveda RM
%A McGarvey ST
%A Friedman JF
%A Wu HW
%A Kurtis JD
%J J Infect Dis
%V 0
%N 0
%D 2024 Jun 29
%M 38942608
%F 7.759
%R 10.1093/infdis/jiae330
%X Immunomodulation enhances parasite fitness by reducing inflammation-induced morbidity in the mammalian host, as well as by attenuating parasite-targeting immune responses. Using a whole proteome differential screening method, we identified Schistosoma japonicum Helminth Defense Molecule (SjHDM-1) as a target of antibodies expressed by S. japonicum resistant, but not susceptible, individuals. In a longitudinal cohort study (N=644) conducted in a S. japonicum endemic region of the Philippines, antibody levels to SjHDM-1 did not predict resistance to reinfection but were associated with increased measures of inflammation. Individuals with high levels of anti-SjHDM-1 IgG had higher levels of C-reactive protein compared to individuals with low anti-SjHDM-1. High anti-SjHDM-1 IgG responses were also associated with reduced biomarkers of nutritional status (albumin), as well as decreased anthropometric measures of nutritional status (WAZ and HAZ) and increased measures of hepatomegaly. Our results suggest that anti-SjHDM-1 responses inhibit the immunomodulatory function of SjHDM-1, resulting in increased morbidity.